- Home
- ASND vs EHC Comparison
ASND vs EHC Comparison
Compare ASND & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- EHC
- Stock Information
- Founded
- ASND 2006
- EHC 1983
- Country
- ASND Denmark
- EHC United States
- Employees
- ASND N/A
- EHC N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- EHC Hospital/Nursing Management
- Sector
- ASND Health Care
- EHC Health Care
- Exchange
- ASND Nasdaq
- EHC Nasdaq
- Market Cap
- ASND 8.8B
- EHC 9.5B
- IPO Year
- ASND 2015
- EHC 1986
- Fundamental
- Price
- ASND $126.66
- EHC $96.88
- Analyst Decision
- ASND Strong Buy
- EHC Strong Buy
- Analyst Count
- ASND 13
- EHC 8
- Target Price
- ASND $195.00
- EHC $104.13
- AVG Volume (30 Days)
- ASND 537.5K
- EHC 576.6K
- Earning Date
- ASND 11-05-2024
- EHC 10-28-2024
- Dividend Yield
- ASND N/A
- EHC 0.70%
- EPS Growth
- ASND N/A
- EHC 25.88
- EPS
- ASND N/A
- EHC 3.92
- Revenue
- ASND $340,327,869.00
- EHC $5,070,900,000.00
- Revenue This Year
- ASND $16.12
- EHC $11.83
- Revenue Next Year
- ASND $87.44
- EHC $9.01
- P/E Ratio
- ASND N/A
- EHC $24.70
- Revenue Growth
- ASND 166.54
- EHC 10.86
- 52 Week Low
- ASND $85.29
- EHC $57.55
- 52 Week High
- ASND $161.00
- EHC $98.74
- Technical
- Relative Strength Index (RSI)
- ASND 38.86
- EHC 61.94
- Support Level
- ASND $125.40
- EHC $92.93
- Resistance Level
- ASND $132.63
- EHC $98.74
- Average True Range (ATR)
- ASND 4.46
- EHC 1.37
- MACD
- ASND -1.87
- EHC 0.09
- Stochastic Oscillator
- ASND 5.19
- EHC 67.99
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.